ALKERMES | ALKS - 贷款资金

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	贷款资金	更改		日
AbbVie	USD 62.97B		12M	2025-09
Acadia Pharmaceuticals	USD 0		0	2025-03
ALKERMES	USD 285.82M		639K	2024-09
Amgen	USD 50B		2.43B	2025-12
Biogen	USD 6.29B		1.4M	2025-09
BioMarin Pharmaceutical	USD 597.18M		513K	2025-12
Bristol-Myers Squibb	USD 42.85B		1.62B	2025-12
Coherus Biosciences	USD 51.08M		496K	2025-12
Eli Lilly	USD 40.87B		5.6M	2025-12
Gilead Sciences	USD 22.13B		6M	2025-12
Heron Therapeutics	USD 140.64M		975K	2025-12
Ionis Pharmaceuticals	USD 1.9B		1.87B	2025-12
J&J	USD 37.53B		1.91B	2026-03
Malin Corporation	EUR 0		0	2024-12
Merck	USD 39.97B		6B	2025-09
Minerva Neurosciences	USD 0		86.58M	2024-09
Nektar Therapeutics	USD 63.16M		44.35M	2025-12
Neurocrine Biosciences	USD 169.5M		500K	2023-03
Otsuka Holdings	JPY 166.92B		6.35B	2025-12
Ovoca Bio	EUR 0		0	2021-06
Pfizer	USD 57.41B		93M	2025-09
Regeneron Pharmaceuticals	USD 2.71B		720.4M	2025-12
Vertex Pharmaceuticals	USD 111.4M		1.4M	2025-03